Skip to Main Content
An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Browse Lab Results > 2010-0042

Trial Summary

About CDAS Project, PI, Publications: Evaluation of a four kallekrein panel to detect prostate cancer

Datasets

Site: Prostate

Inclusion Criteria:

  • No Rare Cancers
  • No Prior History of Any Cancer
  • No Biopsies Prior to Randomization
  • Has Biopsy
  • Has PSA >= 4 During Biopsy Year
  • Age at PSA <= 75
  • No Uknown Gleason in Cases
  • Has Any Serum Available
  • Has Serum Available in Same Year as PSA (Eligible)
  • 1000 Selected at Random Proportional to Eligibles (Selected)

Match Ratio: Proportional to Eligibles

Match Technique: N/A

Additional Matching Comments: No true match, only selection of 1000 random subjects targeting African Americans first.

Analytes:

  • Beta-Microseminoprotein
  • Free PSA
  • Prostate Specific Antigen Inactive
  • Total Human Glandular Kallikrein-2
  • Total PSA

Number of Cases: 341

Number of Controls: 659